DarioHealth Corp (DRIO)

Currency in USD
8.820
-0.110(-1.23%)
Real-time Data·
DRIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.8109.370
52 wk Range
5.93517.744
Key Statistics
Prev. Close
8.93
Open
9.37
Day's Range
8.81-9.37
52 wk Range
5.935-17.744
Volume
3.73K
Average Volume (3m)
17.43K
1-Year Change
-38.75%
Book Value / Share
13.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DRIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.000
Upside
+126.76%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

DarioHealth Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DarioHealth Corp Earnings Call Summary for Q4/2025

  • DarioHealth's 2025 revenue fell 17% to $22.4M due to legacy client non-renewal; Q4 showed sequential growth to $5.2M with 2% stock gain after-hours.
  • Gross margin expanded 800 basis points to 57% in 2025; operating expenses cut 31% to $49.3M, improving operating loss by $21M year-over-year.
  • Company pivoting to multi-condition digital care platforms with AI-driven efficiencies to enhance competitive positioning and reduce operational costs.
  • Management expects 2026 revenue growth from new client wins and contract ramp-ups, with strongest acceleration anticipated in second half of year.
  • Key risks include client non-renewals, digital health competition, AI integration execution, economic healthcare spending pressures, and regulatory changes.
Last Updated: 19-03-2026, 06:56 pm
Read Full Transcript

Compare DRIO to Peers and Sector

Metrics to compare
DRIO
Peers
Sector
Relationship
P/E Ratio
−1.8x−0.5x−0.5x
PEG Ratio
−0.05−0.010.00
Price/Book
0.8x1.2x2.6x
Price / LTM Sales
2.4x0.9x3.2x
Upside (Analyst Target)
124.0%68.0%53.4%
Fair Value Upside
Unlock29.5%7.7%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 20.000
(+126.76% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
TD Cowen
Hold11.00+24.72%0.60Maintain14-11-2025
Stifel
Buy16.00+81.41%1.25Maintain14-11-2025
TD Cowen
Hold0.60-93.20%1.00Maintain13-08-2025
Stifel
Buy1.25-85.83%1.50Maintain13-08-2025
Litchfield Hills Research
Buy3.00-65.99%-New Coverage19-05-2025

Earnings

Latest Release
13-11-2025
EPS / Forecast
-2.96 / -0.19
Revenue / Forecast
5M / 8.54M
EPS Revisions
Last 90 days

DRIO Income Statement

FAQ

What Is the DarioHealth (DRIO) Stock Price Today?

The DarioHealth stock price today is 8.820.

What Stock Exchange Does DarioHealth Trade On?

DarioHealth is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for DarioHealth?

The stock symbol for DarioHealth is "DRIO."

What Is the DarioHealth Market Cap?

As of today, DarioHealth market cap is 59.610M.

What Is DarioHealth's Earnings Per Share (TTM)?

The DarioHealth EPS (TTM) is -11.364.

When Is the Next DarioHealth Earnings Date?

DarioHealth will release its next earnings report on 13-11-2025.

From a Technical Analysis Perspective, Is DRIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has DarioHealth Stock Split?

DarioHealth has split 4 times.

How Many Employees Does DarioHealth Have?

DarioHealth has 199 employees.

What is the current trading status of DarioHealth (DRIO)?

As of 19-03-2026, DarioHealth (DRIO) is trading at a price of 8.820, with a previous close of 8.930. The stock has fluctuated within a day range of 8.810 to 9.370, while its 52-week range spans from 5.935 to 17.744.

What Is DarioHealth (DRIO) Price Target According to Analysts?

The average 12-month price target for DarioHealth is USD20.000, with a high estimate of USD28 and a low estimate of USD11. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +126.76% Upside potential.

What Is the DRIO Premarket Price?

DRIO's last pre-market stock price is 9.270. The pre-market share volume is 510.000, and the stock has decreased by 0.340, or 3.810%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.